FWG-16244-05935
1 vaccination
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 930 / CA
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-21
- 2021-02-26
-
2021-08-13
Survey response — 6 months, dose 1MedDRA: Hypertrophic cardiomyopathy, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Probably unrelated, but hypertrophic cardiomyopathy after having palpitations.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 1
Symptoms: Probably unrelated, but hypertrophic cardiomyopathy after having palpitations.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertrophic cardiomyopathy | ✓ | · | ✓ |
| SD | Palpitations | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release